Outset Medical, Inc. (OM)
After hours:
| Previous close | 3.0000 |
| Open | 3.0300 |
| Bid | 3.0900 x 200 |
| Ask | 3.1500 x 400 |
| Day's range | 3.0300 - 3.2400 |
| 52-week range | 1.9200 - 24.1300 |
| Volume | |
| Avg. volume | 970,330 |
| Market cap | 162.345M |
| Beta (5Y monthly) | 1.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.4800 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.79 |
Business WireOutset Medical to Present at Upcoming Investor Conferences
SAN JOSE, Calif., May 01, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate at the BofA Securities Health Care conference on Tuesday, May 14, 2024 at 2:20 p.m. Eastern time/11:20 a.m. Pacific time, and at the RBC Capital Markets Global Health Care conference on Wednesday, May 15, 2024 at 1:35 p.m. Eastern time/10:35 a.
Business WireOutset Medical to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
SAN JOSE, Calif., April 19, 2024--Outset Medical, Inc. (Nasdaq: OM) ("Outset"), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the first quarter of 2024 after the close of trading on Wednesday, May 8, 2024.
ZacksOutset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
Outset Medical's (OM) latest agreement is likely to provide patients and caregivers access to innovative home dialysis with the Tablo Hemodialysis System.
